Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Picankibart in adolescent moderate to severe plaque psoriasis
NCT07265284Phase 3Recruiting
- Sponsor
- Innovent Biologics
- Start
- Dec 2025
- Primary completion
- Sep 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of picankibart in plaque psoriasis, sponsored by Innovent Biologics. Started Dec 2025; status: recruiting.
02
Drugs
picankibart
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07265284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07265284.